|
Disease |
|
|
|
Detail |
hsa-miR-21 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-9-2 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-10b |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-123 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-128a |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-130a |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-181b |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-181c |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-23a |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-23b |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-24-1 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-24-2 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-25 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-181a |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-220 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-221 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-222 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-125b-1 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-125b-2 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-191 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-197 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
hsa-miR-21 |
|
Causal |
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. |
2005 |
|
|
|
|
|
|
hsa-miR-221 |
|
Causal |
Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. |
2007 |
|
|
|
|
|
|
hsa-miR-222 |
|
Causal |
Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. |
2007 |
|
|
|
|
|
|
hsa-miR-7 |
|
Causal |
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. |
2008 |
|
|
|
|
|
|
hsa-miR-153 |
|
Causal |
Down-regulations of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1) by MicroRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. |
2009 |
|
|
|
|
|
|
hsa-miR-21 |
|
Causal |
MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. |
2008 |
|
|
|
|
|
|
hsa-miR-425 |
|
Unspecified |
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. |
2008 |
|
|
|
|
|
|
hsa-miR-451 |
|
Causal |
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. |
2008 |
|
|
|
|
|
|
hsa-miR-486 |
|
Unspecified |
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. |
2008 |
|
|
|
|
|
|
hsa-miR-21 |
|
Causal |
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. |
2009 |
|
|
|
|
|
|
hsa-miR-7 |
|
Causal |
Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. |
2009 |
|
|
|
|
|
|
hsa-miR-34a |
|
Causal |
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes |
2009 |
|
|
|
|
|
|